Shares of Assembly Biosciences advanced after the company reported encouraging results from a clinical trial of its treatment for the hepatitis B virus. The stock was up 5.2% at $15.49 in premarket ...
Consuming two daily doses of baking soda — in the form of four or five 650-milligram tablets — was linked with slower kidney disease progression over five years, according to the study published ...